Edition:
United States

People: Johnson & Johnson (JNJ)

JNJ on New York Consolidated

135.22USD
19 Sep 2017
Change (% chg)

-- (--)
Prev Close
$135.22
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,620,201
52-wk High
$137.08
52-wk Low
$109.32

Washington, A. Eugene 

Dr. A. Eugene Washington, M.D. is an Independent Director of Johnson & Johnson. Dr. Washington is currently Duke University’s Chancellor for Health Affairs and the President and Chief Executive Officer of the Duke University Health System. Previously he was Vice Chancellor of Health Sciences, Dean of the David Geffen School of Medicine at UCLA; Chief Executive Officer of the UCLA Health System; and Distinguished Professor of Gynecology and Health Policy at UCLA. Prior to UCLA, he served as Executive Vice Chancellor and Provost at the University of California, San Francisco (UCSF) from 2004 to 2010. Dr. Washington co-founded UCSF’s Medical Effectiveness Research Center for Diverse Populations in 1993 and served as Director until 2005. He was Chair of the Department of Obstetrics, Gynecology, and Reproductive Sciences at UCSF from 1996 to 2004. Dr. Washington also co-founded the UCSF-Stanford Evidence-based Practice Center and served as its first Director from 1997 to 2002. Prior to UCSF, Dr. Washington worked at the Centers for Disease Control and Prevention. Dr. Washington was elected to the National Academy of Sciences’ Institute of Medicine in 1997, where he served on its governing Council. He was founding Chair of the Board of Governors of the Patient-Centered Outcomes Research Institute, served as a member of the Scientific Management Review Board for the National Institutes of Health, and also served as Chair of the Board of Directors of both the California HealthCare Foundation and The California Wellness Foundation. Dr. Washington currently serves on the Boards of Directors of the Kaiser Foundation Hospitals and Kaiser Foundation Health Plan, Inc.

Basic Compensation

Total Annual Compensation, USD 110,000
Restricted Stock Awards, USD 164,985
Long-Term Incentive Plans, USD --
All Other, USD 20,000
Fiscal Year Total, USD 294,985

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alex Gorsky

26,871,700

Dominic Caruso

11,304,800

Peter Fasolo

3,621,280

Paulus Stoffels

12,725,500

Michael Ullmann

5,676,350

Joaquin Duato

10,104,500
As Of  31 Dec 2016